Clinical Trial Update: Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating olmesartan alone or with hydrochlorothiazide in adults with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Olmesartan (olmesartan)

Snippet

Sponsor: Pfizer | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED